This course offers a focused guide to the FDA’s rule classifying simple in vitro diagnostic devices for detecting secreted proteins from Bacillus species in human clinical samples as Class II with special controls. Learn actionable steps for compliance, including labeling, distribution, validation, and biosafety requirements, essential for manufacturers, laboratories, and regulatory professionals seeking to ensure device safety, legal distribution, and reliable performance in clinical settings.
In this course you will learn the following:
* Understand the scope and intent of the FDA’s final rule for these diagnostic devices.
* Identify the key requirements and special controls now enforceable by law.
* Implement the necessary steps to ensure compliance with the new classification and special controls.
* Recognize the legal and regulatory consequences of failing to comply with the rule.
